These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5188348)

  • 1. [Experience with paraoxypropiophenone (Frenantol) in the treatment of dysplasias and metastasized carcinoma of the breast].
    Grapulin G
    Chir Ital; 1967 Jun; 19(3):306-12. PubMed ID: 5188348
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of vitamin C for bone metastasis.
    Postgrad Med; 1972 Aug; 52(2):24. PubMed ID: 5047027
    [No Abstract]   [Full Text] [Related]  

  • 3. Calusterone in the therapy for advanced breast cancer.
    Gordan GS; Wessler S; Avioli LV
    JAMA; 1972 Jan; 219(4):483-90. PubMed ID: 5066641
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trial hormone therapy of advanced breast cancers with calusterone. Preliminary study of 41 cases].
    Brule G; Chauvergne J; Clavel B; Gary-Bobo J; Gurrin J; Klein T; Pommatau E
    Sem Hop; 1974 Dec 8-14; 50(50-51):3099-105. PubMed ID: 4377318
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
    Mannes P; Derriks R
    Acta Tuberc Pneumol Belg; 1968; 59(2):445-54. PubMed ID: 5720490
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of estrogen-gestagen combination therapy in advanced breast carcinoma with special reference to pulmonary metastases].
    Berndt G; Eckel H; Notter G; St Stender H
    Strahlentherapie; 1971 May; 141(5):540-8. PubMed ID: 5088730
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypercalcemia in patients with advanced mammary cancer and osseous metastases. Effect of hormone therapy and schedule of treatment.
    Donovan AJ; Bethune JE; Berne TV
    Am Surg; 1966 Oct; 32(10):673-80. PubMed ID: 5921429
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined chemo-radiotherapeutic treatment of breast neoplasms at the metastatis stage].
    Agati G; Stoppa IM
    J Radiol Electrol Med Nucl; 1967 Nov; 48(11):803-4. PubMed ID: 5591688
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical results of combination therapy with 32 Phosphorus and anabolics agents in multiple bone metastasis].
    Kleibel F
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:66-7. PubMed ID: 4341233
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of advanced mammary carcinomas with high-dosed cytostatics].
    Boeckl O; Heitz N; Wasl H; Karrer K; Mannheimer E
    Munch Med Wochenschr; 1965 Oct; 107(43):2114-8. PubMed ID: 5899028
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of a new synthetic progestative agent in high dosage (ethynodiol diacetate) in the treatment of advanced forms of adenocarcinoma of the corpus uteri (apropos of 2 illustrative cases)].
    Luzuy M; Soutoul JH; Luzuy R
    Chirurgie; 1970 Oct; 96(12):859-67. PubMed ID: 5502831
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of effective bisphosphonate therapy for bone metastasis from breast cancer with multiorganic metastases].
    Sueyoshi K; Ogura Y; Komori T; Takahashi M; Tian TX; Tatsumi T; Matsuki M; Saika Y; Uesugi Y; Utsunomiya K; Inomata Y; Narabayashi I
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1795-9. PubMed ID: 12402432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal treatment with non-virilizing androgens, in a case of extensive bone metastasis of an epithelioma of the breast].
    Tardiveau J; Philippon J
    J Radiol Electrol Med Nucl; 1970 Dec; 51(12):801-2. PubMed ID: 5510215
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transient bone marrow inhibition caused by aminoglutethimide].
    Tel W; van Lijf JH; ten Napel CH
    Ned Tijdschr Geneeskd; 1989 Jan; 133(3):126-8. PubMed ID: 2922066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of malignant disease metastatic to bone by hormonal alterations.
    Mellette SJ
    Clin Orthop Relat Res; 1970; 73():73-88. PubMed ID: 5479779
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of a cyclophosphamide therapy in genital and mammary carcinomas].
    Naumann R
    Zentralbl Gynakol; 1970 May; 92(22):700-2. PubMed ID: 5284155
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot study.
    van Oosterom AT; Powles TJ; Hamersma E; Smith IE; Engelsman E
    Eur J Cancer (1965); 1980; Suppl 1():275-6. PubMed ID: 6797825
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with Masterid].
    Heine R
    Med Welt; 1971 Apr; 17():718-20. PubMed ID: 4930464
    [No Abstract]   [Full Text] [Related]  

  • 19. Sex chromatin and hormonal treatment in breast cancer with bone metastases.
    Siracká E; Siracký J
    Neoplasma; 1969; 16(2):205-8. PubMed ID: 5822920
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of calcitonin in the treatment of bone metastases of prostatic carcinoma].
    Di Silverio F; Giacobini S; Liberti M; Fragomeri R; Petrone U
    Clin Ter; 1977 Oct; 83(1):3-15. PubMed ID: 589946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.